OCGN Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
1.5M
-2.9%
1.5M
1.8M
+27.6%
1.4M
Cost of Revenue
0
0
0
0
0
Gross Profit
1.5M
-2.9%
1.5M
1.8M
+27.6%
1.4M
Operating Expenses
17.9M
-7.4%
19.4M
19.4M
+27.7%
15.2M
R&D
10.7M
-5.0%
11.3M
11.1M
+32.7%
8.4M
SG&A
7.2M
-10.8%
8.1M
8.2M
+21.6%
6.8M
Operating Income
-16444000
+7.8%
-17839000
-17625000
-27.8%
-13795000
EBITDA
-15858000
+8.1%
-17249000
-4244.8%
-397000
+97.6%
-16675000
-32.8%
-12554000
Net Income
-24877000
-29.7%
-19177000
-20051000
-36.0%
-14739000
EPS (Basic)
$-0.07
-16.7%
$-0.06
$-0.07
-40.0%
$-0.05
EPS (Diluted)
$-0.07
-16.7%
$-0.06
$-0.07
-40.0%
$-0.05
Shares (Diluted)
338.7M
+3.4%
327.5M
+4.8%
312.6M
+2.8%
304.0M
+4.1%
292.1M
Ocugen (OCGN) — Financials